Cargando…
Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts
OBJECTIVES: Odontogenic keratocyst (OKC) presents considerable variation in aggressiveness and propensity for recurrence, yet hitherto, no explicit clinicopathological features have been determined to clearly demonstrate the potential for relapse. This retrospective study aims to investigate the pro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224022/ https://www.ncbi.nlm.nih.gov/pubmed/29508125 http://dx.doi.org/10.1007/s00784-018-2400-7 |
_version_ | 1783369522915311616 |
---|---|
author | Kaczmarzyk, Tomasz Kisielowski, Konrad Koszowski, Rafał Rynkiewicz, Magdalena Gawełek, Ewa Babiuch, Karolina Bednarczyk, Anna Drozdzowska, Bogna |
author_facet | Kaczmarzyk, Tomasz Kisielowski, Konrad Koszowski, Rafał Rynkiewicz, Magdalena Gawełek, Ewa Babiuch, Karolina Bednarczyk, Anna Drozdzowska, Bogna |
author_sort | Kaczmarzyk, Tomasz |
collection | PubMed |
description | OBJECTIVES: Odontogenic keratocyst (OKC) presents considerable variation in aggressiveness and propensity for recurrence, yet hitherto, no explicit clinicopathological features have been determined to clearly demonstrate the potential for relapse. This retrospective study aims to investigate the prognostic relevance of various clinicopathological features as well as immunoexpression of COX-2, bcl-2, PCNA, and p53 in sporadic OKC. MATERIALS AND METHODS: Among 41 patients with OKC treated by enucleation, the frequency of recurrence for various clinicopathological features as well as immunoexpression for COX-2, bcl-2, PCNA, and p53 was evaluated. RESULTS: The mean follow-up was 8.49 years, and recurrences were ascertained in 29.27% of cases. We found significant differences between recurrent and non-recurrent cysts in terms of multilocularity (P = 0.029), cortical perforation (P = 0.001), and lesion size (P < 0.001). Hazard risk for the recurrence was 3.362 (95% CI 1.066–10.598) for multilocular cysts, 7.801 (95% CI 2.1–28.985) for evidence of cortical perforation, and 1.004 (1.002–1.006) for 1 mm(2) of lesion size on panoramic radiographs. We also found that immunoexpression of PCNA significantly correlates with the radiographic evidence of cortical perforation (P = 0.048) and that there is significant positive correlation between expression of COX-2 and bcl-2 (P = 0.001) as well as significant negative correlation between immunoexpression of COX-2 and age (P = 0.002). None of the other analyzed factors were associated with the recurrence. CONCLUSIONS: Larger size, multilocularity, and cortical perforation in sporadic OKC may be correlated with the relapse. CLINICAL RELEVANCE: Immunohistochemical analyses of COX-2, bcl-2, PCNA, and p53 lack prognostic utility in sporadic OKC. |
format | Online Article Text |
id | pubmed-6224022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-62240222018-11-19 Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts Kaczmarzyk, Tomasz Kisielowski, Konrad Koszowski, Rafał Rynkiewicz, Magdalena Gawełek, Ewa Babiuch, Karolina Bednarczyk, Anna Drozdzowska, Bogna Clin Oral Investig Original Article OBJECTIVES: Odontogenic keratocyst (OKC) presents considerable variation in aggressiveness and propensity for recurrence, yet hitherto, no explicit clinicopathological features have been determined to clearly demonstrate the potential for relapse. This retrospective study aims to investigate the prognostic relevance of various clinicopathological features as well as immunoexpression of COX-2, bcl-2, PCNA, and p53 in sporadic OKC. MATERIALS AND METHODS: Among 41 patients with OKC treated by enucleation, the frequency of recurrence for various clinicopathological features as well as immunoexpression for COX-2, bcl-2, PCNA, and p53 was evaluated. RESULTS: The mean follow-up was 8.49 years, and recurrences were ascertained in 29.27% of cases. We found significant differences between recurrent and non-recurrent cysts in terms of multilocularity (P = 0.029), cortical perforation (P = 0.001), and lesion size (P < 0.001). Hazard risk for the recurrence was 3.362 (95% CI 1.066–10.598) for multilocular cysts, 7.801 (95% CI 2.1–28.985) for evidence of cortical perforation, and 1.004 (1.002–1.006) for 1 mm(2) of lesion size on panoramic radiographs. We also found that immunoexpression of PCNA significantly correlates with the radiographic evidence of cortical perforation (P = 0.048) and that there is significant positive correlation between expression of COX-2 and bcl-2 (P = 0.001) as well as significant negative correlation between immunoexpression of COX-2 and age (P = 0.002). None of the other analyzed factors were associated with the recurrence. CONCLUSIONS: Larger size, multilocularity, and cortical perforation in sporadic OKC may be correlated with the relapse. CLINICAL RELEVANCE: Immunohistochemical analyses of COX-2, bcl-2, PCNA, and p53 lack prognostic utility in sporadic OKC. Springer Berlin Heidelberg 2018-03-05 2018 /pmc/articles/PMC6224022/ /pubmed/29508125 http://dx.doi.org/10.1007/s00784-018-2400-7 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Kaczmarzyk, Tomasz Kisielowski, Konrad Koszowski, Rafał Rynkiewicz, Magdalena Gawełek, Ewa Babiuch, Karolina Bednarczyk, Anna Drozdzowska, Bogna Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title | Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title_full | Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title_fullStr | Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title_full_unstemmed | Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title_short | Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts |
title_sort | investigation of clinicopathological parameters and expression of cox-2, bcl-2, pcna, and p53 in primary and recurrent sporadic odontogenic keratocysts |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224022/ https://www.ncbi.nlm.nih.gov/pubmed/29508125 http://dx.doi.org/10.1007/s00784-018-2400-7 |
work_keys_str_mv | AT kaczmarzyktomasz investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT kisielowskikonrad investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT koszowskirafał investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT rynkiewiczmagdalena investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT gawełekewa investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT babiuchkarolina investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT bednarczykanna investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts AT drozdzowskabogna investigationofclinicopathologicalparametersandexpressionofcox2bcl2pcnaandp53inprimaryandrecurrentsporadicodontogenickeratocysts |